Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activityfor a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

1) Define current barriers to the delivery of healthcare to urban children;
2) Discuss a cost-effective approach to the evaluation and treatment of common pediatric illnesses;
3) To demonstrate and apply the principles of case-based learning to the development of differential diagnosis, treatment and follow-up of patients with a variety of pediatric disorders;
4) To analyze the clinical care provided to patients by members of the faculty in the Department of Pediatrics at Boston Medical Center.

Target Audience

Pediatric faculty, house staff, nursing staff and physicians from outside the institution, including associated neighborhood health centers.

Faculty Disclosure

Faculty, Planning Committee and CME Administratopr disclosure statement:

James Xie, Speaker, has no relevant financial relationships to disclose.

Robert Vinci, Course Director, has no relevant financial relationships to disclose.

Katherine Nash, Planning Committee, has no relevant financial relationships to disclose.

Laura Chiel, Planning Committee, has no relevant financial relationships to disclose.

Sakina Flint, RSS Coordinator, has no relevant financial relationships to disclose.

Faculty disclosure of off-label use:

Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.